Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.

van der Pol P, Liebregts N, Brunt T, van Amsterdam J, de Graaf R, Korf DJ, van den Brink W, van Laar M.

Addiction. 2014 Jul;109(7):1101-9. doi: 10.1111/add.12508. Epub 2014 Mar 17.

PMID:
24628797
2.

Validation of self-reported cannabis dose and potency: an ecological study.

van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M.

Addiction. 2013 Oct;108(10):1801-8. doi: 10.1111/add.12226. Epub 2013 May 30.

PMID:
23627816
3.

Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

Freeman TP, Morgan CJ, Hindocha C, Schafer G, Das RK, Curran HV.

Addiction. 2014 Oct;109(10):1686-94. doi: 10.1111/add.12634. Epub 2014 Jul 16.

PMID:
24894801
4.

Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.

Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA.

Ther Drug Monit. 2014 Apr;36(2):218-24. doi: 10.1097/FTD.0b013e3182a5c446.

5.

Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.

Korf DJ, Benschop A, Wouters M.

Int J Drug Policy. 2007 May;18(3):168-76. Epub 2006 Sep 25.

PMID:
17689363
6.

Commentary on van der Pol et al. (2014): Reconsidering the association between cannabis exposure and dependence.

Temple EC.

Addiction. 2014 Jul;109(7):1110-1. doi: 10.1111/add.12580. No abstract available.

PMID:
24903289
7.

Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

Hunault CC, Mensinga TT, de Vries I, Kelholt-Dijkman HH, Hoek J, Kruidenier M, Leenders ME, Meulenbelt J.

Psychopharmacology (Berl). 2008 Dec;201(2):171-81. doi: 10.1007/s00213-008-1260-2. Epub 2008 Aug 10.

PMID:
18695931
8.

Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.

van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M.

Drug Alcohol Depend. 2013 Dec 1;133(2):352-9. doi: 10.1016/j.drugalcdep.2013.06.009. Epub 2013 Jul 22.

9.

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Hunault CC, Mensinga TT, Böcker KB, Schipper CM, Kruidenier M, Leenders ME, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2009 May;204(1):85-94. doi: 10.1007/s00213-008-1440-0. Epub 2008 Dec 20.

PMID:
19099294
11.

Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model.

Hunault CC, van Eijkeren JC, Mensinga TT, de Vries I, Leenders ME, Meulenbelt J.

Toxicol Appl Pharmacol. 2010 Aug 1;246(3):148-53. doi: 10.1016/j.taap.2010.04.019. Epub 2010 May 4.

PMID:
20450927
12.

Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.

Böcker KB, Gerritsen J, Hunault CC, Kruidenier M, Mensinga TT, Kenemans JL.

Pharmacol Biochem Behav. 2010 Jul;96(1):67-74. doi: 10.1016/j.pbb.2010.04.008. Epub 2010 Apr 24.

PMID:
20417659
13.

Tetrahydrocannabinol content and differences in marijuana smoking behavior.

Herning RI, Hooker WD, Jones RT.

Psychopharmacology (Berl). 1986;90(2):160-2.

PMID:
3024196
14.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.

Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA.

Clin Chem. 2013 Dec;59(12):1770-9. doi: 10.1373/clinchem.2013.207316. Epub 2013 Aug 12.

15.

Passive cannabis smoke exposure and oral fluid testing.

Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ.

J Anal Toxicol. 2004 Oct;28(7):546-52.

PMID:
15516313
16.

Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.

Bonnet U, Specka M, Stratmann U, Ochwadt R, Scherbaum N.

Drug Alcohol Depend. 2014 Oct 1;143:189-97. doi: 10.1016/j.drugalcdep.2014.07.027. Epub 2014 Aug 1.

PMID:
25127704
17.
18.

Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.

Lundahl LH, Greenwald MK.

Drug Alcohol Depend. 2015 Apr 1;149:187-93. doi: 10.1016/j.drugalcdep.2015.01.046. Epub 2015 Feb 11.

PMID:
25725933
19.

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.

Fabritius M, Chtioui H, Battistella G, Annoni JM, Dao K, Favrat B, Fornari E, Lauer E, Maeder P, Giroud C.

Anal Bioanal Chem. 2013 Dec;405(30):9791-803. doi: 10.1007/s00216-013-7412-1. Epub 2013 Nov 8.

PMID:
24202191
20.

Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.

Cooper ZD, Haney M.

Int Rev Psychiatry. 2009 Apr;21(2):104-12. doi: 10.1080/09540260902782752. Review.

Supplemental Content

Support Center